Your browser doesn't support javascript.
loading
SEOM-GECOD clinical guideline for unknown primary cancer (2021).
Losa, Ferrán; Fernández, Isaura; Etxaniz, Olatz; Giménez, Alejandra; Gomila, Paula; Iglesias, Lara; Longo, Federico; Nogales, Esteban; Sánchez, Antonio; Soler, Gemma.
Afiliação
  • Losa F; Hospital de Sant Joan Despí Moisés Broggi-ICO Hospitalet, Barcelona, Spain. ferran.losa@sanitatintegral.org.
  • Fernández I; Hospital Álvaro Cunqueiro-IIGS, Vigo, Spain.
  • Etxaniz O; Hospital Germans Trias I Pujol -ICO Badalona, Barcelona, Spain.
  • Giménez A; Hospital Lluís Alcanys de Xàtiva, Valencia, Spain.
  • Gomila P; Hospital Miguel Servet (Zaragoza)/H, de Barbastro, Spain.
  • Iglesias L; Hospital Universitario 12 de Octubre, Madrid, Spain.
  • Longo F; Hospital Universitario Ramón y Cajal, IRYCIS, CIBERONC, Madrid, Spain.
  • Nogales E; Hospital Universitario Virgen Macarena, Sevilla, Spain.
  • Sánchez A; Hospital Universitario Puerta de Hierro Majadahonda, Madrid, Spain.
  • Soler G; Hospital Durán i Reynals-ICO Hospitalet, Barcelona, Spain.
Clin Transl Oncol ; 24(4): 681-692, 2022 Apr.
Article em En | MEDLINE | ID: mdl-35320504
ABSTRACT
Cancer of unknown primary site (CUP) is defined as a heterogeneous group of tumors that appear as metastases, and of which standard diagnostic work-up fails to identify the origin. It is considered a separate entity with a specific biology, and nowadays molecular characteristics and the determination of actionable mutations may be important in a significant group of patients. In this guide, we summarize the diagnostic, therapeutic, and possible new developments in molecular medicine that may help us in the management of this unique disease entity.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Primárias Desconhecidas Tipo de estudo: Diagnostic_studies / Guideline / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Primárias Desconhecidas Tipo de estudo: Diagnostic_studies / Guideline / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article